基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
夏赞贤,男,汉族,教授,2013年?>中南大学特聘研究员。博士生导师。现工作于中南大学生命科学学院。1998年于中国科学院上海生物化学与细胞生物学研究所获得博士学位,随后在美国加州理工学院(Caltech)、南加州大学(USC)和一家生物制药公司以博士后和高级科学家等身份从事泛素系统的结构功能、WNT/β-catenin信号途径的蛋白质组学、蛋白抗体药物的筛选以及对多种实体瘤的治疗应用的机制研究。在PNAS, Molecular and Cellular Biology, Journal of Biological Chemistry, Journal of Proteomics, Proteomics,Journal of Molecular Cell Biology,The Journal of Nuclear Medicine,PLoS ONE等国际学术期刊发表20多篇研究论文,引用总次数超过300次。[1]
研究方向:
1. 肿瘤、肿瘤细胞和肿瘤干细胞的蛋白质泛素化的蛋白质组学研究
2. WNT/β-catenin信号途径与多药耐药(MDR)的调控机制
3. 靶向EphB4-EphrinB2信号途径的肿瘤治疗策略
研究方向:
1. 肿瘤、肿瘤细胞和肿瘤干细胞的蛋白质泛素化的蛋白质组学研究
2. WNT/β-catenin信号途径与多药耐药(MDR)的调控机制
3. 靶向EphB4-EphrinB2信号途径的肿瘤治疗策略
Research Interests
Papers共 74 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Qingtian Gao,Sixu Liu,Yuzheng Zhou,Jinbao Fan, Shufen Ke, Yuqing Zhou, Kaiqiang Fan, Yuxuan Wang,Yingjun Zhou,Zanxian Xia,Xu Deng
European Journal of Medicinal Chemistry (2024): 116498-116498
Yuzheng Zhou,Zongpeng Chen, Sijie Liu,Sixu Liu,Yujie Liao,Ashuai Du,Zijun Dong, Yongxing Zhang, Xuan Chen,Siyi Tao, Xin Wu,Aroona Razzaq,
Signal transduction and targeted therapyno. 1 (2024): 159-159
REVIEWS IN MEDICAL VIROLOGYno. 1 (2024): e2500-e2500
SCIENTIA SINICA Vitaeno. 8 (2023): 1083-1100
Biochimie (2022): 39-53
Advances in Microbiologyno. 04 (2022): 198-217
Sijia Li,Siyuan Yang,Yuzheng Zhou,Cyrollah Disoma,Zijun Dong,Ashuai Du,Yongxing Zhang,Yong Chen, Weiliang Huang,Junru Chen, Deqiang Song,Zongpeng Chen,
Load More
Author Statistics
#Papers: 77
#Citation: 4747
H-Index: 24
G-Index: 68
Sociability: 6
Diversity: 0
Activity: 1
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn